MSS/ MMRp

Who we are

  • April 5, 2022
    Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases
  • April 5, 2022
    A Trial of Ipatasertib in Combination With Atezolizumab
  • April 5, 2022
    Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
  • April 5, 2022
    Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer
  • April 5, 2022
    Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease
  • April 5, 2022
    Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors
  • April 5, 2022
    Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases
  • April 5, 2022
    Curative Proton Beam Therapy for Patients With Liver Metastasis of Colorectal Cancer
  • April 5, 2022
    Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies
  • April 5, 2022
    Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer